DE60107444D1 - Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen - Google Patents

Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen

Info

Publication number
DE60107444D1
DE60107444D1 DE60107444T DE60107444T DE60107444D1 DE 60107444 D1 DE60107444 D1 DE 60107444D1 DE 60107444 T DE60107444 T DE 60107444T DE 60107444 T DE60107444 T DE 60107444T DE 60107444 D1 DE60107444 D1 DE 60107444D1
Authority
DE
Germany
Prior art keywords
treatment
edems
pollen extract
extract container
pollen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60107444T
Other languages
English (en)
Other versions
DE60107444T2 (de
Inventor
Kaj Winter
Christer Hedman
Lars Kaernerud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATUMIN PHARMA HUSKVARNA AB
Original Assignee
NATUMIN PHARMA HUSKVARNA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATUMIN PHARMA HUSKVARNA AB filed Critical NATUMIN PHARMA HUSKVARNA AB
Publication of DE60107444D1 publication Critical patent/DE60107444D1/de
Application granted granted Critical
Publication of DE60107444T2 publication Critical patent/DE60107444T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Insects & Arthropods (AREA)
  • Obesity (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
DE60107444T 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen Expired - Lifetime DE60107444T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003092 2000-09-01
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use
PCT/SE2001/001848 WO2002017941A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema

Publications (2)

Publication Number Publication Date
DE60107444D1 true DE60107444D1 (de) 2004-12-30
DE60107444T2 DE60107444T2 (de) 2005-12-08

Family

ID=20280860

Family Applications (5)

Application Number Title Priority Date Filing Date
DE60107444T Expired - Lifetime DE60107444T2 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
DE60108402T Expired - Lifetime DE60108402D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
DE60107441T Expired - Lifetime DE60107441D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
DE60107442T Expired - Lifetime DE60107442D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit
DE60107443T Expired - Lifetime DE60107443D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen

Family Applications After (4)

Application Number Title Priority Date Filing Date
DE60108402T Expired - Lifetime DE60108402D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
DE60107441T Expired - Lifetime DE60107441D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
DE60107442T Expired - Lifetime DE60107442D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit
DE60107443T Expired - Lifetime DE60107443D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen

Country Status (10)

Country Link
EP (5) EP1313495B1 (de)
JP (5) JP4896354B2 (de)
AT (5) ATE283061T1 (de)
AU (7) AU2001282813A1 (de)
CA (5) CA2420906C (de)
DE (5) DE60107444T2 (de)
NO (1) NO330691B1 (de)
PL (1) PL202468B1 (de)
SE (1) SE0003092D0 (de)
WO (5) WO2002017944A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005139150A (ja) * 2003-11-10 2005-06-02 Api Co Ltd エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN104027100A (zh) * 2014-06-12 2014-09-10 山东中弘信息科技有限公司 一种基于最近历史值的血压异常数据处理方法
KR101533197B1 (ko) * 2014-09-18 2015-07-02 성균관대학교산학협력단 부테인을 포함하는 부종의 예방 또는 치료용 조성물
FR3055215B1 (fr) 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN106138856A (zh) * 2016-09-30 2016-11-23 四川易创生物科技有限公司 一种治疗经间期出血的新型中药组合物及制备方法
EP3335717A1 (de) * 2016-12-13 2018-06-20 Serelys Pharma S.A.M. Zusammensetzung zur verwendung bei der behandlung von symptomen im zusammenhang mit prämenstruellem syndrom (pms)
FR3070263B1 (fr) 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2970957B2 (ja) * 1991-05-15 1999-11-02 株式会社グレイトチレン 精製花粉栄養調整物
ES2081255B1 (es) * 1994-01-05 1996-09-01 Ind Farma Especial Aplicacion de las proteinas receptoras de autoincompatibilidad (slsg) de plantas para el tratamiento de las enfermedades alergicas.
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH09278665A (ja) * 1996-04-10 1997-10-28 Api Kk 花粉エキスソフトカプセル剤及びその製造方法
EP1057483B1 (de) * 1998-02-23 2007-02-21 Taiyo Kagaku Co., Ltd. Theanin-beinhaltende zusammenstellung

Also Published As

Publication number Publication date
ATE283061T1 (de) 2004-12-15
WO2002017943A1 (en) 2002-03-07
CA2424146A1 (en) 2002-03-07
WO2002017941A1 (en) 2002-03-07
JP4896354B2 (ja) 2012-03-14
AU8458101A (en) 2002-03-13
EP1313496B1 (de) 2004-11-24
AU2001282816A1 (en) 2002-03-13
AU8281401A (en) 2002-03-13
JP2004507509A (ja) 2004-03-11
WO2002017940A1 (en) 2002-03-07
EP1313495A1 (de) 2003-05-28
WO2002017944A1 (en) 2002-03-07
CA2420823A1 (en) 2002-03-07
EP1313492B1 (de) 2004-11-24
WO2002017942A1 (en) 2002-03-07
ATE283059T1 (de) 2004-12-15
NO20030988L (no) 2003-03-03
CA2420906A1 (en) 2002-03-07
ATE283060T1 (de) 2004-12-15
SE0003092D0 (sv) 2000-09-01
EP1313496A1 (de) 2003-05-28
AU2001282814B2 (en) 2006-12-21
EP1313493A1 (de) 2003-05-28
DE60107443D1 (de) 2004-12-30
DE60108402D1 (de) 2005-02-17
DE60107444T2 (de) 2005-12-08
EP1313492A1 (de) 2003-05-28
JP2004507508A (ja) 2004-03-11
EP1313494A1 (de) 2003-05-28
DE60107441D1 (de) 2004-12-30
CA2424026A1 (en) 2002-03-07
JP2004507507A (ja) 2004-03-11
NO20030988D0 (no) 2003-03-03
EP1313494B1 (de) 2005-01-12
DE60107442D1 (de) 2004-12-30
EP1313495B1 (de) 2004-11-24
JP2004507510A (ja) 2004-03-11
CA2420823C (en) 2014-07-15
EP1313493B1 (de) 2004-11-24
CA2420906C (en) 2014-07-15
ATE283058T1 (de) 2004-12-15
AU2001282815A1 (en) 2002-03-13
CA2424011A1 (en) 2002-03-07
AU2001282813A1 (en) 2002-03-13
JP2004507506A (ja) 2004-03-11
NO330691B1 (no) 2011-06-14
PL202468B1 (pl) 2009-06-30
ATE286739T1 (de) 2005-01-15
AU2001284581B2 (en) 2006-09-21
PL360652A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
EP0249735A3 (de) Als aktives Mittel 2-Phenyl-1,2-benzisoselenazol-3(2H)-on enthaltende pharmazeutische Zubereitungen zur Behandlung von durch oxidativen Stress verursachten Krankheiten
DE69931907D1 (de) Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
DE60107444D1 (de) Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
ATE284996T1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
TR200100637T2 (tr) Yeni doğal ürün türevleri
WO2001043705A3 (en) Compositions containing a retinoid and a stilbene for skin care
BR0314787A (pt) Forma de dosagem de liberação modificada
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
NO901076L (no) Substituerte bifenyler.
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
WO2002036747A3 (en) Peripheral nerve type sodium channels
BG104029U (en) Formulation for the treatment of dermatozoonoses
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA
MD2230G2 (ro) Unguent sulfurat
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами

Legal Events

Date Code Title Description
8364 No opposition during term of opposition